glp 1 and eating disorders GLP-1 obesity drugs are not well understood yet : NPR GLP-1RAs and Obesity Associated with
Description
& Kaplan, J
GLP-1 receptor agonists and gastric emptying interactions
Lingvay I, Cohen RV, le Roux CW, Sumithran P
The dose is adjusted based on basal blood glucose level every three days (Table 1)
When selecting the most appropriate agent, a comprehensive review of all head-to-head data indicates that liraglutide appears to still offer the best A1C and weight reduction, while the once weekly agents may cause less GI AEs compared with the once daily or twice daily options
GLP1 receptor agonists for the treatment of obesity: Role as a promising approach
